Archive for March 26th, 2012|Daily archive page


In STEM CELLS IN THE NEWS on March 26, 2012 at 8:44 pm

“Bi-Stem Cell” describes a researcher who goes both ways; delving into the areas of both Adult and Embryonic…or maybe even iPSC if they are really open minded.  I did a quick check on the internet and I do believe I’ve coined this term.



  1. The Vatican is pro-Adult stem cells first for religious reasons (based on the controversy associated with  Embryonic stem cells) and secondly because Adult stem cell treatments work and Embryonic do not (see Stem Cells 101).
  2. The Vatican publicizes a stem cell conference and invites two speakers who happen to research both Adult AND Embryonic stem cells.
  3. How should the Vatican handle these “bi-stem cell” speakers?

Now that we’re up to speed:

The Vatican  asked the two “bi-stem cell” speakers to only speak about Adult stem cells and they agreed. 

Imagine, you bring in speakers who ‘go both ways’ and get them to talk only about the benefits of going…one of the ways.  Their very silence on the subject of Embryonic stem cells is an indictment of Embryonic and an endorsement of Adult stem cells.  Not a bad plan if it works; but then…it all went sideways.  Apparently, the prelates raised concerns about how bi-stem cell scientists would confuse the masses, the conference was ultimately cancelled and now the Vatican public relations stem cell endeavor is tripping over its own feet. 


Can science and religion peacefully co-exist? I don’t know…

but while this new ‘Black Vatican Eye’ is unfortunate, the real damage is to the millions of people who look to the Vatican for guidance in life and death decisions and will not see these two scientists extolling the proven virtues of the safety and therapeutic benefits of Adult stem cells. The ramification of this fumble effects not only the eternal souls of the churches members but also the extension of their health, longevity and quality of life AND the potential postponement of their deaths.

-David Granovsky

Canceled Stem Cell Conference is Another Black Eye for the Vatican


Vatican (Photo credit: tejvanphotos)

I think the ghost of Teilhard de Chardin haunts the Vatican.

Whatever merits Pope Benedict deserves as a theologian, his papacy seems to be marked by one public relations debacle after another.

The latest black eye comes with the report this past Friday that the Pontifical Academy for Life is canceling a much publicized stem cell conference that was to take place next month, featuring (among many others) speakers like Douglas Melton and George Daley, leading researchers from the Harvard Stem Cell Institute.

The Third International Congress on Responsible Stem Cell Research was going to commence  at the Vatican on April 25th, for three days of presentations and discussion and to conclude with an audience with Pope Benedict XVI.

According to David Kerr’s report, one member of the Academy, who did not wish to be identified, had this to say: “I am infinitely relieved that the Church has avoided a major blunder which would have confused the faithful for decades to come.”

He then added, implausibly, “The Holy Spirit has certainly shown to be present through those faithful members who drew attention to the ambiguity of the choice of speakers. I hope and pray that a review will be affected of the basis on which these congresses are planned.”

As is well known, the Catholic Church is opposed to embryonic stem cell research, judging it as unethical because it involves the willful destruction of human embryos.

Melton and Daley conduct research using both embryonic and adult stem cells, but their agreement was to discuss only the latter at the conference…

Canceled Stem Cell Conference is Another Black Eye for the Vatican – Forbes.


In DISEASE INFO on March 26, 2012 at 1:17 am


I was told this was a con…here is my response:

My Stem Cells vs. Stroke page:

Additional articles sorted by date (YEAR/MONTH/DAY):




A con? Ok my skeptical friends, I understand. You’ve been researching stroke treatments for so long and been so disheartened you don’t believe your condition can ever improve. You’ve read all the outdated literature saying the central nervous system can not regrow (except for the most recent studies which prove it can be.) You’ve skimmed my articles and realize they are uncorroborated by “hard science.”

Fair enough. Ignore the 14 articles above which show the positive benefits of adult stem cells on stroke. You’re right, they are unsubstantiated. They are not peer reviewed medical journal articles. I appreciate your skepticism but know this:

*there are over 2,600 peer reviewed medical journal clinical trials that utilized adult stem cells with a record of safety and efficacy,
*there are many trials that cover the use of adult stem cells for stroke, ataxia, TBI, etc
*there are 60 trials that have the key words “adult stem cell” and “stroke.”
*there are 14 “Completed” trials that have the key words “adult stem cell” and “stroke.”

Research it yourself if you like. http://clinicaltrials.gov/ct2/results?term=adult+stem+cell+stroke&pg=1&show_flds=Y

Here are only the 14 “completed” trials:

Completed Efficacy Study of CD34 Stem Cell in Chronic Stroke Patients

Conditions: Stroke;   Middle Cerebral Artery Infarction
Interventions: Procedure: Intercerebral implantation of Autulogous Stem Cells;   Drug: convention therapy
Completed Intravenous Autologous Bone Marrow-derived Stem Cells Therapy for Patients With Acute Ischemic Stroke

Condition: Acute Stroke
Intervention: Biological: Autologous bone marrow stem cell
Completed Autologous Bone Marrow Stem Cells in Middle Cerebral Artery Acute Stroke Treatment.

Conditions: Stroke, Acute;   Infarction, Middle Cerebral Artery
Intervention: Procedure: Infusion on autologous CD34+ stem cells into middle cerebral artery
Completed Study of Autologous Stem Cell Transplantation for Patients With Ischemic Stroke

Condition: Infarction, Middle Cerebral Artery
Intervention: Other: Autologous cell transplantation
21 Completed Granulocyte-colony Stimulating Factor for Stem Cells Therapy for Acute Ischemic Stroke

Condition: Ischemic Stroke
Intervention: Drug: Filgrastim
31 Completed Sickle Cell Disease and Endothelial Progenitor Cells (EPCs)

Condition: Sickle Cell Anemia
Intervention: Procedure: Angiography
34 Completed Investigating Endothelial Precursor Cells (EPCs)

Condition: Central Nervous System
38 Completed Immunological Mechanisms of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis

Condition: Multiple Sclerosis
Intervention: Procedure: Stem Cell Transplanataion
40 Completed Gene Therapy for Gaucher’s and Fabry Disease Using Viruses and Blood-Forming Cells

Condition: Gaucher’s Disease
Intervention: Genetic: human glucocerebrosidase cDNA
51 Completed Single-Dose Pharmacokinetics (PK) Study of Novel Neurogenic Compound NSI-189

Condition: Depression
Intervention: Drug: NSI-189 Phosphate
52 Completed Beta-hCG + Erythropoietin in Acute Stroke

Condition: Acute Stroke
Intervention: Drug: Beta-hCG + Erythropoietin
54 Completed Effects of Hyperbaric Oxygen Therapy in Autistic Children: A Pilot Study

Conditions: Autism;   Oxidative Stress;   Inflammation
Intervention: Drug: Hyperbaric Oxygen Therapy
59 Completed Effects of Enzyme Replacement in Gaucher’s Disease

Condition: Gaucher’s Disease
60 Completed Incidence of Ocular Antibodies in Patients With Sturge – Weber Syndrome (SWS)

Condition: Sturge – Weber Syndrome (SWS)



If you still feel this is a con, tell me what you would need to see to prove otherwise. Respectfully, David

%d bloggers like this: